The Effect of add-on Canagliflozin in Patients With Type 2 Diabetes Treated With U-500 Insulin

NCT02597309 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Diabetes, Obesity

Interventions

DRUG: Canagliflozin

Sponsor

Joslin Diabetes Center